Ro 31‐8220 suppresses bladder cancer progression via enhancing autophagy in vitro and in vivo
The pan‐protein kinase C inhibitor Ro‐31‐8220 demonstrates potent anti‐bladder cancer effects both in vitro and in vivo by suppressing migration/invasion, inducing apoptosis and crucially activating autophagy, where blocking autophagy with chloroquine reduces its cell‐killing efficacy, suggesting its promise as a novel therapeutic candidate requiring ...
Shengjun Fu+12 more
wiley +1 more source
Novel Protein Kinase Inhibitors: SMART Drug Design Technology
Tomi K. Sawyer+9 more
doaj +1 more source
Updated analysis of the prescription and evaluation of protein kinase inhibitors for oncology in Germany. [PDF]
Obst CS, Seifert R.
europepmc +1 more source
Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis. [PDF]
Pereira Moreira B+6 more
europepmc +1 more source
Vinblastine accumulation induced by protein kinase inhibitors in rat ascites hepatoma AH66 cells
Shinya Wakusawa+3 more
openalex +1 more source
High LRIG1 expression predicts lymph node metastasis in patients with uterine cervical cancer
Lymph node status is crucial in determining treatment for women with early‐stage cervical cancer. We demonstrate that high LRIG1 protein expression in primary tumors can predict lymph node metastases. Our findings support further investigation of LRIG1 as a biomarker to improve staging accuracy and guide treatment decisions in cervical cancer patients.
Pernilla Israelsson+5 more
wiley +1 more source
Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors. [PDF]
Kandeel MM+4 more
europepmc +1 more source
Oncotherapeutic Protein Kinase Inhibitors Associated With Pro-Arrhythmic Liability. [PDF]
Ye JZ, Hansen FB, Mills RW, Lundby A.
europepmc +1 more source
Calcium-dependent protein kinases and their selective inhibitors
Satoshi Matsushima+3 more
openalex +1 more source